<html>
<head>PUBMED IDs for PRKG2</head>
<body bgcolor='#C5F0F2'><h1>PRKG2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/16596286/'>Comparative integromics on BMP/GDF family.</a> April 6  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/18166785/'>Activity of imatinib in systemic mastocytosis with chronic basophilic leukemia and a PRKG2-PDGFRB fusion.</a> January 2  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18262053/'>Fusion of PRKG2 and SPTBN1 to the platelet-derived growth factor receptor beta gene (PDGFRB) in imatinib-responsive atypical myeloproliferative disorders.</a> February 12  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18551195/'>Phosphorylation of GSK-3beta by cGMP-dependent protein kinase II promotes hypertrophic differentiation of murine chondrocytes.</a> June 14  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/20522426/'>Microdeletion at chromosome 4q21 defines a new emerging syndrome with marked growth restriction, mental retardation and absent or severely delayed speech.</a> September 16  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/22303795/'>8.6Mb interstitial deletion of chromosome 4q13.3q21.23 in a boy with cognitive impairment, short stature, hearing loss, skeletal abnormalities and facial dysmorphism.</a> March 7  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22903878/'>Life-history chronicle for a patient with the recently described chromosome 4q21 microdeletion syndrome.</a> February 21  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23913759/'>Expanding the spectrum of microdeletion 4q21 syndrome: a partial phenotype with incomplete deletion of the minimal critical region and a new association with cleft palate and Pierre Robin sequence.</a> March 29  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23913758/'>Fibroblast growth factor receptor-1 as a potential therapeutic target in sinonasal cancer.</a> May 13  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23913756/'>Population-specific frequencies for LRRK2 susceptibility variants in the Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium.</a> June 21  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24065112/'>Copy number variants in patients with short stature.</a> January 27  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24882840/'>Common variants of cGKII/PRKG2 are not associated with gout susceptibility.</a> February 24  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25688884/'>Polymorphism of rs7688672 and rs10033237 in cGKII/PRKG2 and gout susceptibility of Han population in northern China.</a> May 16  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27288323/'>A de novo microtriplication at 4q21.21-q21.22 in a patient with a vascular malignant hemangioma, elongated sigmoid colon, developmental delay, and absence of speech.</a> June 12  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28371330/'>A de novo deletion in a boy with cerebral palsy suggests a refined critical region for the 4q21.22 microdeletion syndrome.</a> April 4  2017<br><a href='https://pubmed.ncbi.nlm.nih.gov/28371317/'>Molecular characterization of acute lymphoblastic leukemia with high CRLF2 gene expression in childhood.</a> April 4  2017<br></body></html>
